These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33462212)

  • 1. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
    Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
    Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
    Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
    Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
    Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
    Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
    Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
    J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
    Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
    Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.
    Huang MY; Xuan F; Liu W; Cui HJ
    Oncogene; 2017 Jan; 36(3):387-396. PubMed ID: 27292258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation.
    Mallm JP; Windisch P; Biran A; Gal Z; Schumacher S; Glass R; Herold-Mende C; Meshorer E; Barbus M; Rippe K
    Int J Cancer; 2020 Mar; 146(5):1281-1292. PubMed ID: 31456217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype.
    Katainen R; Donner I; Räisänen M; Berta D; Kuosmanen A; Kaasinen E; Hietala M; Aaltonen LA
    J Med Genet; 2022 Jul; 59(7):644-651. PubMed ID: 34281993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription.
    Jie X; Fong WP; Zhou R; Zhao Y; Zhao Y; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
    Cell Death Differ; 2021 Jul; 28(7):2095-2111. PubMed ID: 33558705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth.
    Gregory BL; Cheung VG
    Genome Res; 2014 Jan; 24(1):52-63. PubMed ID: 24285722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.
    Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W
    Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of histone H3 lysine demethylases in glioblastoma.
    Young D; Guha C; Sidoli S
    Cancer Metastasis Rev; 2023 Jun; 42(2):445-454. PubMed ID: 37286866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
    Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
    Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
    Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
    Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
    Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
    Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.